Pharmaceutical - Women's Health, Novartis


Current filters:

Women's HealthNovartis

Popular Filters

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon


In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Alliance Pharma buys expanded rights to Syntometrine from Novartis


UK specialty drugmaker Alliance Pharma (AIM: APH) says it has acquired all existing rights to Syntometrine…

Alliance PharmaMarkets & MarketingNovartisPharmaceuticalSyntometrineWomen's Health

Back to top